Skip to content

Drug interactions

Oxaliplatin + Ustekinumab

Severity: Moderate

Oxaliplatin and Ustekinumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Oxaliplatin causes myelosuppression and ustekinumab modulates immune responses, so together they may increase susceptibility to infection. The clinical significance depends on the patient's neutrophil count and overall immune status.

What this interaction means in plain words

Oxaliplatin and Ustekinumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Oxaliplatin belongs to Oncology; Ustekinumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression from cytotoxic myelosuppression and IL-12/23 blockade.

What to do

Monitor blood counts and for signs of infection during chemotherapy; consider holding ustekinumab during severe neutropenia or active infection.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Oxaliplatin and Ustekinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Oxaliplatin with Ustekinumab?

MediHelp rates the interaction as moderate. Oxaliplatin and Ustekinumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oxaliplatin causes myelosuppression and ustekinumab modulates immune responses, so together they may increase susceptibility to infection. The clinical significance depends on the patient's neutrophil count and overall immune status.

How serious is the interaction between Oxaliplatin and Ustekinumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for signs of infection during chemotherapy; consider holding ustekinumab during severe neutropenia or active infection.

What other medicines interact with Ustekinumab?

MediHelp also lists interactions of Ustekinumab with, for example, Bcg vaccine live, Typhoid vaccine live, Adalimumab. The full list is on the Ustekinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in